コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 mice exhibited a severe symptom of allergic lung inflammation.
2 del with concomitantly reduced virus-induced lung inflammation.
3 s breathing activity did not increase global lung inflammation.
4 ar epithelial regeneration and resolution of lung inflammation.
5 s increased house-dust-mite-specific IgE and lung inflammation.
6 allenged with IL-33 and assessed for AHR and lung inflammation.
7 mately 92 cluster in ILC2s displayed reduced lung inflammation.
8 rden and histopathologic evidence of chronic lung inflammation.
9 neumoniae to induce either lung infection or lung inflammation.
10 d with IRF4 and NFAT1 expression in allergic lung inflammation.
11 - and Alternaria-induced ILC2 activation and lung inflammation.
12 irrespective of aggregation during skin and lung inflammation.
13 Nippostrongylus brasiliensis or induction of lung inflammation.
14 gregation, stronger and prolonged anemia and lung inflammation.
15 ILC2 development and restores IL-33-mediated lung inflammation.
16 tial of VLA-4 as a surrogate marker of acute lung inflammation.
17 no signs of hemorrhage in models of skin or lung inflammation.
18 the effects of IL-33 on ILC2 activation and lung inflammation.
19 C2-mediated airway hyperreactivity (AHR) and lung inflammation.
20 e recruitment and ultimately contributing to lung inflammation.
21 act (HDE), to test their role in maintaining lung inflammation.
22 es isolated from aged blood into mice caused lung inflammation.
23 ysis, in vitro proinflammatory activity, and lung inflammation.
24 ultiple adverse clinical sequelae, including lung inflammation.
25 rentiating K. pneumoniae lung infection from lung inflammation.
26 les were unaffected by the presence of acute lung inflammation.
27 el in mice, and blocked papain-induced acute lung inflammation.
28 this can lead to susceptibility to asthmatic lung inflammation.
29 crease in metabolic activity associated with lung inflammation.
30 t and activation of specific immune cells in lung inflammation.
31 nd IL-1RI upregulation on the development of lung inflammation.
32 ncy attenuates atherosclerosis but not acute lung inflammation.
33 -/-) mice, including increased mortality and lung inflammation.
34 urther showed that AM pyroptosis exaggerates lung inflammation.
35 PEG-PTX conjugates induced lung inflammation.
36 ring influenza infection to limit widespread lung inflammation.
37 e end of the imaging period was unaltered by lung inflammation.
38 innate lymphoid cell (ILC) 2 during allergic lung inflammation.
39 luding increased mortality, weight loss, and lung inflammation.
40 c target for treating ILC2-mediated allergic lung inflammation.
41 ection, but they also contribute to allergic lung inflammation.
42 ultiple adverse clinical sequelae, including lung inflammation.
43 lonella, bacteria previously associated with lung inflammation.
44 aB inhibitor) markedly mitigated mouse acute lung inflammation.
45 only attenuated RV-induced CXCL-10, but also lung inflammation.
46 are resistant to the development of allergic lung inflammation.
47 h HMPV displayed less airway dysfunction and lung inflammation.
48 mproved histologic lung injury, and dampened lung inflammation.
49 nto nascent alveoli at sites of interstitial lung inflammation.
50 role for autophagy as negative regulator of lung inflammation.
51 nous pathways that help to control excessive lung inflammation.
52 tion between platelets and AECs during acute lung inflammation.
53 d interaction in human ILC2s reduced AHR and lung inflammation.
54 oimmunity in systemic lupus erythematosus or lung inflammation.
55 denosine aggravated ragweed-induced allergic lung inflammation.
56 mast cell accumulation in models of allergic lung inflammation.
57 ms also operated during HDM-induced allergic lung inflammation.
58 expression, neutralization of which reduced lung inflammation.
59 clearance and facilitate resolution of acute lung inflammation.
60 elper 2 (Th2) cytokines that promote AHR and lung inflammation.
61 ng of ovalbumin- and house dust mite-induced lung inflammation.
62 treatment option for HDM-induced allergy and lung inflammation.
63 etabolic change in the lung affects allergic lung inflammation.
64 ce, indicating that type III IFN exacerbates lung inflammation.
65 environment and increases offspring allergic lung inflammation.
66 ar fraction which corresponded to protracted lung inflammation.
67 responsiveness in a murine model of allergic lung inflammation.
68 t for four consecutive days to induce innate lung inflammation.
69 as well as reversal of established allergic lung inflammation.
70 s, and plays an important role in infectious lung inflammation.
71 bese people are more susceptible to allergic lung inflammation.
72 nce resolution of lipopolysaccharide-induced lung inflammation.
73 and assessed for airway hyperreactivity and lung inflammation.
74 hyperactivation and consequent experimental lung inflammation.
75 ment significantly alleviated both joint and lung inflammation.
76 elays the recovery process from neutrophilic lung inflammation.
78 dust mite (HDM)-induced asthma-like allergic lung inflammation, a collagen-induced arthritis, an indu
79 sculin significantly suppressed neutrophilic lung inflammation, a hallmark of acute lung injury (ALI)
80 mpaired chloride permeability and persistent lung inflammation, a multidrug approach is required for
86 infection, ovalbumin (OVA)-induced allergic lung inflammation (ALI) was induced in mice followed by
87 Influenza induced persistent parenchymal lung inflammation, alveolar epithelial metaplasia, and e
88 of blocking IgG induction and suppression of lung inflammation and airway hyperresponsiveness, but SC
90 and sufficient for B. cenocepacia-triggered lung inflammation and also protects mice from lethal B.
93 oxP/loxP) SPC Cre(+) mice confirmed elevated lung inflammation and attenuated alveolar fluid clearanc
95 ils in TLR2KO mice by targeting Ly6G reverts lung inflammation and bacterial burden to levels compara
96 er understanding of the interactions between lung inflammation and barrier framework could lead to th
97 )) is produced in the airway during allergic lung inflammation and both promotes and inhibits feature
98 on of the ambient air pollutant ozone causes lung inflammation and can suppress host defense mechanis
99 gnaling via this receptor results in reduced lung inflammation and cellular recruitment as well as re
100 activates the NLRP3 inflammasome and induces lung inflammation and cellular recruitment that is NLRP3
101 ptible to bacterial infections, which worsen lung inflammation and contribute to lung function declin
103 to examine the role of FABP5 in the allergic lung inflammation and demonstrated that the expression o
104 - mice also show viral persistence, enhanced lung inflammation and elevated pro-inflammatory cytokine
105 ction faster than controls and had decreased lung inflammation and endoplasmic reticulum stress.
106 te respiratory distress syndrome by reducing lung inflammation and enhancing alveolar fluid clearance
109 reveals a hierarchy of immune abnormalities, lung inflammation and fibrosis, which do not depend on e
111 ulmonary artery thrombosis because of severe lung inflammation and hypercoagulability rather than thr
112 n IP(-/-) mice restored both the HDM-induced lung inflammation and ILC2 numbers, whereas transfer of
114 et activation, which is a major driver of CF lung inflammation and impaired bacterial clearance.
115 Despite the different accumulation, the lung inflammation and inflammatory T cell responses were
117 Mechanical ventilation caused significant lung inflammation and injury that was prevented in the p
118 r lavage (BAL) fluid showed that LPS-induced lung inflammation and injury were significantly inhibite
119 sgene overexpression reduced E. coli-induced lung inflammation and injury, decreased nuclear factor-k
120 Chronic asthma is associated with persistent lung inflammation and long-term remodelling of the airwa
121 improve our understanding and management of lung inflammation and lung disease throughout the natura
122 early half of subjects experienced worsening lung inflammation and lung function at Week 4 of ART.
123 cases of an HDM-induced asthma-like allergic lung inflammation and of a collagen-induced arthritis, t
125 CFTR in platelets produced exaggerated acute lung inflammation and platelet activation after intratra
127 ral factor in the pathogenesis of persistent lung inflammation and protein-rich edema formation, the
129 )Cu-alphaCD11b PET/CT readily detected acute lung inflammation and recruitment of CD11b(+) myeloid ce
130 Bronchiectasis is a disorder of persistent lung inflammation and recurrent infection, defined by a
131 ciated with higher viral loads and increased lung inflammation and reduced influenza A virus-specific
132 and potential links among diabetes, O3, and lung inflammation and remodeling are currently unknown.
133 -biased airway inflammation that can develop lung inflammation and remodeling of the respiratory trac
136 laying a role in dampening LPS-induced acute lung inflammation and suggest that C1P could be a valuab
137 PPP1R11 in mouse lungs significantly affects lung inflammation and the clearance of Staphylococcus au
138 e sought to address the role of autophagy in lung inflammation and the pathogenesis of corticosteroid
140 ognized role for MMP-28 in promoting chronic lung inflammation and tissue remodeling induced by cigar
141 was to assess the variation in AgNP-induced lung inflammation and toxicity across multiple inbred mo
142 rodent studies indicate that AgNPs can cause lung inflammation and toxicity in a strain- and particle
143 efore sensitization exacerbated eosinophilic lung inflammation and type 2 cytokine production in resp
144 d infiltration of neutrophils during sterile lung inflammation and were less sensitive to bacterial s
145 ne innate immune cellular and cytokine-based lung inflammation and were resistant to lethal influenza
146 neutrophil accumulation in a model of acute lung inflammation and, at 0.001 mg/kg, alleviates pulmon
149 induced airway hyperresponsiveness (AHR) and lung inflammation, and bleomycin-induced lung fibrosis;
150 and emerging PET techniques for quantifying lung inflammation, and discuss potential clinical applic
152 th increased airway and tissue eosinophilia, lung inflammation, and IL-4, IL-5, IL-13, and IgE produc
153 T mice, sensitized PHIL mice maintained AHR, lung inflammation, and increased levels of IL-4, IL-5, a
154 mediating airway hyperresponsiveness (AHR), lung inflammation, and mucus metaplasia in a dual Th2/Th
155 rp78 deletion caused weight loss, mortality, lung inflammation, and spatially heterogeneous fibrosis
156 c improvement in pulmonary function, reduced lung inflammation, and the rapid clearance of the Pneumo
159 ed no significant toxicity or indications of lung inflammation, as assessed by cell population count
160 duction also decreased viral replication and lung inflammation, as evidenced by a reduced neutrophil
162 ng antigen doses, we observed an increase in lung inflammation associated with an upregulation of pro
164 finally allows prediction of the spectrum of lung inflammation associated with materials of interest
165 mice exhibited exacerbated protease-induced lung inflammation associated with reduced numbers of reg
166 reus pneumonia is characterized by extensive lung inflammation associated with severe morbidity and m
167 d pulmonary pathology in a model of allergic lung inflammation but also reduced ability to combat inf
169 lone is necessary and sufficient to regulate lung inflammation but it has no direct antiviral activit
170 lating basal airway function and LPS-induced lung inflammation, but does not play a role in bleomycin
172 ic cells enhances resolution of experimental lung inflammation by incompletely understood mechanisms.
173 at ACE2 inhibits neutrophil infiltration and lung inflammation by limiting IL-17 signaling by reducin
174 of mouse ILC-intrinsic Arg1 abrogated type 2 lung inflammation by restraining ILC2 proliferation and
175 inflammation in a mouse model of LPS-induced lung inflammation by significantly reducing the release
176 er inflammation-related diseases such as the lung inflammation caused by the newly identified COVID-1
178 inhalation of SplD without adjuvant induced lung inflammation characterized by TH2 cytokines and eos
181 n vivo, CO(2) -RWE induced stronger allergic lung inflammation compared to control-RWE, as indicated
184 ental allergens and less severe IL-33-driven lung inflammation, correlating with an impaired expansio
185 ) on CD4 T cells is required for OVA-induced lung inflammation, DCs have also been shown to be target
186 ocomotor activity in parallel with increased lung inflammation, disrupted rhythms of pulmonary functi
187 th Haemophilus influenzae resulted in lethal lung inflammation due to massive production of proinflam
190 e of host IL-6 response in the regulation of lung inflammation during AA and the control of S. pneumo
191 abilize dependent lung regions reduce global lung inflammation during mechanical ventilation, indepen
192 e-signaling pathways to reduce or ameliorate lung inflammation during respiratory viral infections is
193 n AA model, IL-6 deficiency led to increased lung inflammation, eosinophil recruitment, tissue pathol
194 esolving lipid mediators, thereby prolonging lung inflammation evoked by E. coli Genetic deletion of
195 and that mice and humans with NEC-associated lung inflammation express higher levels of pulmonary TLR
196 ngs of mice challenged with HDM allergen and lung inflammation, expression of suppressive molecules,
199 ited exacerbation of cardiac dysfunction and lung inflammation, greater increases in levels of plasma
201 diopulmonary mortality via macrophage-driven lung inflammation; however, the mechanisms are incomplet
204 ked the same direction of change in regional lung inflammation in 98.6% and 84.3% of measurements, re
206 ne cells to inflamed tissues, in quantifying lung inflammation in a mouse model of lipopolysaccharide
207 ET) radiotracer for noninvasive detection of lung inflammation in a mouse model of lung injury and in
208 ion to aeroallergens and consequent allergic lung inflammation in a murine model of chronic asthma.
211 have emerged as major mediators of allergic lung inflammation in animal models as well as humans.
212 ndritic cells (DC) are critical mediators of lung inflammation in asthma, but the characteristics of
214 Intranasal bleomycin challenge exacerbated lung inflammation in autophagy-deficient mice and produc
215 s the major driver of excessive neutrophilic lung inflammation in CGD mice in the early response to f
217 auma and atelectrauma on the distribution of lung inflammation in experimental acute respiratory dist
218 sessed airways hyperresponsiveness (AHR) and lung inflammation in germline and airway smooth muscle-s
221 B cells, dramatically ameliorates kidney and lung inflammation in lupus-prone MRL.Fas(lpr) mice.
222 nted the exaggerated airway eosinophilia and lung inflammation in mice given HDM-pulsed Map3k8(-/-) D
223 PLA2 isoform cPLA2alpha dramatically reduced lung inflammation in mice upon high-dose pulmonary chall
227 ermine the role of IL-6 in the regulation of lung inflammation in murine AA caused by Aspergillus fum
228 ver, FPS-ZM1 treatment significantly reduced lung inflammation in Nrf2(+/+) , but not in Nrf2(-/-) mi
229 S-1 showed lower IL-33 levels and attenuated lung inflammation in response to repetitive Alternaria i
233 ed the severity of OVA/alum-induced allergic lung inflammation in WT BALB/c mice to mice that lack ex
234 y properties in a model of DEP-induced acute lung inflammation, in contrast to anti-inflammatory effe
235 he full therapeutic potential of curcumin in lung inflammation, in this study we utilized a novel wat
237 from Cpn 60.1, named IRL201104, on allergic lung inflammation induced by ovalbumin (OVA) in mice and
240 y is characterized by rapid alveolar injury, lung inflammation, induced cytokine production, neutroph
241 mmation, p52 overexpression caused increased lung inflammation, injury, and mortality following intra
243 me arginase-1 (Arg1) during acute or chronic lung inflammation is a conserved trait of mouse and huma
249 puncture (CLP)-induced sepsis by inhibiting lung inflammation, leukocyte apoptosis, and the producti
250 anscript activity was highly correlated with lung inflammation (lung [(18)F]fluorodeoxyglucose [FDG]
254 -phosphorylated in vivo in acute and chronic lung inflammation models and this response is required t
255 3 have exaggerated neutrophilic/eosinophilic lung inflammation, mucus production, and airway hyperres
256 iate and maintain responses to pneumonia and lung inflammation, often playing a role in resolution, t
257 o effect on MAV-1 replication, virus-induced lung inflammation, or adaptive immunity compared to C57B
258 umor inflammatory stage, TNF-alpha-dependent lung inflammation plays an important role in MHC-II upre
259 ammatory biomarkers to delineate the type of lung inflammation present in asthmatic subjects is incre
260 investigated the effects of human MSC MVs on lung inflammation, protein permeability, bacterial clear
261 review the clinical techniques used to image lung inflammation, provide an overview of clinical and e
263 tion of this normal homeostatic dampening of lung inflammation results in increased resistance to inf
264 ietic deletion of Ship1 leads to spontaneous lung inflammation, selective deletion of Ship1 in T cell
265 deregulation of host erythropoiesis, and the lung inflammation signature was linked to increased neut
267 targets Tregs and ILC2s to restrain allergic lung inflammation, suggesting MaR1 as the basis for a ne
268 istress syndrome, volutrauma promoted higher lung inflammation than atelectrauma at comparable low ti
270 Rationale: In addition to the overwhelming lung inflammation that prevails in COVID-19, hypercoagul
271 didate susceptibility genes for AgNP-induced lung inflammation that warrant additional exploration in
272 dontis and Altenaria alternata induced acute lung inflammation, that inflammation of the pleural cavi
273 monary delivery into mouse models with acute lung inflammation, the volatile reporters are released a
274 staining exhibited goblet cell hyperplasia, lung inflammation, thickening of smooth muscle layer on
275 atopoietic AR expression limits IL-33-driven lung inflammation through a cell-intrinsic inhibition of
276 esearch need for noninvasive ways to monitor lung inflammation through targeting of immunoregulatory
277 es: To test the hypothesis that during acute lung inflammation tissue production of proresolution typ
278 progression of allergen-induced eosinophilic lung inflammation to corticosteroid-refractory neutrophi
279 mouse model of house dust mite (HDM)-induced lung inflammation to explore the potential of laser-faci
281 hese results suggested that the reduction in lung inflammation together with a more robust antiviral
282 Gprc5a-knockout (ko) mice are susceptible to lung inflammation, tumorigenesis and metastasis, which r
283 inflammatory responses in poly(I:C)-induced lung inflammation using a tamoxifen-inducible versican-d
284 ions after 4 weeks of high-fat diet, whereas lung inflammation was assessed after inhalation of lipop
291 om acid sphingomyelinase-deficient mice, and lung inflammation was studied in mice receiving transfus
293 nstrate that signals governing resolution of lung inflammation were altered in Yap/Taz mutant mice, w
294 n of inflammatory cells into the airway, and lung inflammation were enhanced in AT2CC(-/-) mice relat
296 ell trafficking in animal models of allergic lung inflammation, which are known to be platelet depend
298 bone marrow-derived dendritic cells augments lung inflammation with increased IL-17A levels in the lu
299 Zc3h12a(-/-) mice have spontaneous severe lung inflammation, with an increase in mainly IL-5- and